dihydroxyphenylalanine has been researched along with ADDH in 8 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, X | 1 |
Xu, M | 1 |
Hess, EJ | 1 |
Adler, LA | 1 |
Chua, HC | 1 |
Ludolph, AG | 1 |
Kassubek, J | 1 |
Schmeck, K | 1 |
Glaser, C | 1 |
Wunderlich, A | 1 |
Buck, AK | 1 |
Reske, SN | 1 |
Fegert, JM | 1 |
Mottaghy, FM | 1 |
Hanna, GL | 1 |
Ornitz, EM | 1 |
Hariharan, M | 1 |
Ernst, M | 2 |
Zametkin, AJ | 2 |
Matochik, JA | 2 |
Jons, PH | 2 |
Cohen, RM | 2 |
Pascualvaca, D | 1 |
Lupandin, VM | 1 |
Lando, LI | 1 |
Gromova, EA | 1 |
Kamenskaia, VM | 1 |
Zykov, MB | 1 |
Wender, PH | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the Quantified Behavior Test in Patients With Untreated ADHD and Substance Use Disorder[NCT02477280] | Phase 4 | 39 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the Quantified Behavior Test in Patients With Untreated ADHD[NCT02473185] | Phase 4 | 40 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for dihydroxyphenylalanine and ADDH
Article | Year |
---|---|
Management of ADHD in adults.
Topics: Adolescent; Adult; Age Factors; Amphetamines; Antidepressive Agents; Antihypertensive Agents; Attent | 2002 |
Management of ADHD in adults.
Topics: Adolescent; Adult; Age Factors; Amphetamines; Antidepressive Agents; Antihypertensive Agents; Attent | 2002 |
Management of ADHD in adults.
Topics: Adolescent; Adult; Age Factors; Amphetamines; Antidepressive Agents; Antihypertensive Agents; Attent | 2002 |
Management of ADHD in adults.
Topics: Adolescent; Adult; Age Factors; Amphetamines; Antidepressive Agents; Antihypertensive Agents; Attent | 2002 |
7 other studies available for dihydroxyphenylalanine and ADDH
Article | Year |
---|---|
D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Benzopyrans; Corpus Striatum; D | 2010 |
Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; | 2008 |
Urinary catecholamine excretion and behavioral differences in ADHD and normal boys.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child | 1996 |
DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.
Topics: Adult; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Di | 1998 |
High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Caudate Nucleus; Child; Dihydroxyphenylal | 1999 |
[Role of biogenic amines in the pathogenesis of intellectual disorders in children with minimal psychoorganic syndromes].
Topics: Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Dihydroxyphenylalanine; Electr | 1978 |
The minimal brain dysfunction syndrome in children. I. The syndrome and its relevance for psychiatry. II. A psychological and biochemical model for the syndrome.
Topics: Affect; Amphetamine; Arousal; Attention Deficit Disorder with Hyperactivity; Autonomic Nervous Syste | 1972 |